-
- M Howard
- DNAX Research Institute, Palo Alto, California 94304.
-
- T Muchamuel
- DNAX Research Institute, Palo Alto, California 94304.
-
- S Andrade
- DNAX Research Institute, Palo Alto, California 94304.
-
- S Menon
- DNAX Research Institute, Palo Alto, California 94304.
抄録
<jats:p>Interleukin 10 (IL-10) decreases production of IL-1, IL-6, and tumor necrosis factor alpha (TNF-alpha) in vitro, and neutralization of IL-10 in mice leads to elevation of the same monokines. We test here whether this monokine-suppressing property of IL-10 confers on it the capacity to protect mice from lipopolysaccharide-induced shock, a monokine-mediated inflammatory reaction. A single injection of 0.5-1 microgram of recombinant murine IL-10 reproducibly protected BALB/c mice from a lethal intraperitoneal injection of endotoxin. This result was obtained whether the IL-10 was administered concurrently with, or 30 min after the injection of endotoxin. The protective effect of IL-10 was reversed by prior injection of neutralizing anti-IL-10 antibodies, and correlated with a substantial decrease in endotoxin-induced TNF-alpha release. These data implicate IL-10 as a candidate for treatment of bacterial sepsis, and more generally as an effective antiinflammatory reagent.</jats:p>
収録刊行物
-
- The Journal of experimental medicine
-
The Journal of experimental medicine 177 (4), 1205-1208, 1993-04-01
Rockefeller University Press
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361418518497304192
-
- NII論文ID
- 30017433683
-
- ISSN
- 15409538
- 00221007
-
- データソース種別
-
- Crossref
- CiNii Articles